Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Children exposed to hydroxychloroquine in utero show no signs of retinal toxicity at age 5.

Lupus science & medicine·2026
Same author

Patient-clinician communication and cardiovascular outcomes: An analysis of the hispanic community health study/study of latinos (HCHS/SOL), 2008-2019.

American journal of preventive cardiology·2026
Same author

High sodium and low potassium are associated with incident cardiovascular disease among United States Hispanic/Latino adults: prospective results from the Hispanic Community Health Study/Study of Latinos.

The American journal of clinical nutrition·2025
Same author

Cognitive Function as a Predictor of Incident Hypertension in Hispanic/Latino Adults: Results From the Community Health Study/Study of Latinos.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Low Diastolic Blood Pressure and Risk of Ischemic Colitis in the Women's Health Initiative Cohort.

The American journal of gastroenterology·2025
Same author

Long-Term Effect of Multivitamin Supplementation on Incident Self-Reported Hypertension and Blood Pressure Changes in the COSMOS Trial.

American journal of hypertension·2025

Related Experiment Video

Updated: Jun 10, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Statistical analysis of clinical trials.

Sylvia Wassertheil-Smoller1, Mimi Y Kim

  • 1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. sylvia.smoller@einstein.yu.edu

Seminars in Nuclear Medicine
|August 3, 2010
PubMed
Summary

This review covers statistical methods for clinical trial analysis, focusing on discrete, continuous, and time-to-event outcomes. It also addresses challenges like patient noncompliance and missing data in trial design and evaluation.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Evidence-Based Medicine

Background:

  • Randomized clinical trials (RCTs) are the gold standard for evaluating medical interventions.
  • Effective trial design and analysis necessitate clear objectives and appropriate endpoint selection.
  • Statistical considerations are crucial for valid interpretation of clinical trial results.

Purpose of the Study:

  • To provide an overview of fundamental statistical approaches for analyzing clinical trials.
  • To discuss methods for handling common challenges in clinical trial data.
  • To highlight considerations for sample size and statistical power in trial planning.

Main Methods:

  • Statistical analysis of discrete (count), continuous (measurement), and time-to-event (survival) data.
  • Methods for addressing patient noncompliance and loss to follow-up.
  • Techniques for managing missing data and multiple comparisons.

Main Results:

  • Different statistical methods are required based on the nature of the primary endpoint.
  • Protocol deviations, such as noncompliance and drop-out, necessitate specific analytical strategies.
  • Adequate sample size and power are critical for reliable trial outcomes.

Conclusions:

  • Appropriate statistical methods are essential for robust clinical trial analysis.
  • Addressing data complexities ensures the validity and interpretability of trial findings.
  • Sound statistical planning, including sample size determination, underpins successful clinical trials.